In France, as in other industrial countries, the number of ill and dependant elderly people is increasing significantly. At the same time, the number of health professionals and the financial resources remain constant. Consequently, there is a growing interest in providing products and services more adapted to elderly people in autonomy loss situations and to their carers, as well as fostering industries and start-ups to design new successful products and services. However in France, the gerontechnologies which are presently developed are expensive, not adapted to home and institution environments, not flexible enough to be adapted to the variability of situations and disabilities, not refunded and not seriously evaluated. Finally they are remote from the elderly‟s needs, particularly for progressive diseases (Alzheimer, Parkinson). The "Pole Allongement de la Vie Charles Foix‟ was developed in those health and industrial contexts. Created in 1996, it is located in Ivry sur Seine, near Paris, and is part of "Charles Foix Hospital‟.It is affiliated to "Assistance Publique des Hôpitaux de Paris‟ (AP-HP) and to "Université Pierre et Marie Curie‟. It provides a geriatric expertise for more than 10 years, and the will to follow, to support, to advise and to promote the innovative projects in each step of their industrial development. Moreover a fundamental research center on normal and pathological aging (on animal models) is under construction in "Charles Foix Hospital‟. Finally it has been growing a strong partnerships network for many years, notably a first public and private partnership, that was embodied by the signature of a management agreement between "AP-HP‟ and Médialis in 2007.